-
Published 8/23/2025
Lu Z, Zhao Q, Xu H, Katz MH, Wang DS, Andry CD, Yang S. Molecular and Clinicopathological Profiling of Clear Cell Renal Cell Carcinoma with Rhabdoid Features: An Integrative Pathway-Based Stratification Approach. Cancers (Basel). 2025 Aug 23; 17(17). PMID: 40940841.
-
Published 6/4/2024
Labban M, Stone BV, Steele GL, Salinas KE, Agudile E, Katz MH, Rihan-Porter N, Reich AJ, Cole AP, Landers S, Trinh QD. A qualitative approach to understanding the drivers of unequal receipt of definitive therapy for Black men with prostate cancer in Massachusetts. Cancer. 2024 Oct 15; 130 Suppl 20:3590-3601. PMID: 38837334.
-
Published 4/11/2022
Mori JO, Shafran JS, Stojanova M, Katz MH, Gignac GA, Wisco JJ, Heaphy CM, Denis GV. Novel forms of prostate cancer chemoresistance to successful androgen deprivation therapy demand new approaches: Rationale for targeting BET proteins. Prostate. 2022 Jun; 82(10):1005-1015. PMID: 35403746.
-
Published 4/16/2021
Hayek S, Ben-Shlomo Y, Balicer R, Byrne K, Katz M, Kepten E, Raz I, Roitman E, Zychma M, Barda N. Preinfection glycaemic control and disease severity among patients with type 2 diabetes and COVID-19: A retrospective, cohort study. Diabetes Obes Metab. 2021 Aug; 23(8):1995-2000. PMID: 33822446.
-
Published 3/9/2021
Ionson A, Monfared SHB, Ursiny M, Katz M, Wang D, Babayan R, Wason S. Economic Evaluation of 1470?nm Diode Laser Enucleation vs Bipolar Transurethral Resection of the Prostate. J Endourol. 2021 08; 35(8):1204-1210. PMID: 33499745.